Economic Evaluation of Dapagliflozin Versus Metformin in Chinese Patients Whose Diabetes Is Inadequately Controlled With Diet and Exercise

Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/s12962-020-00208-w
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes

Scientific Reports
Multidisciplinary
2019English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Db4 - Cost-Effectiveness of Dapagliflozin in Adult Patients With Inadequately Controlled Type 1 Diabetes: A Health Economic Analysis Using 24-Week Results From the Depict-1 Randomised Controlled Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2012English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Efficiency and Safety of Transfer of Type 2 Diabetes Patients Inadequately Controlled on Metformin Alone to Combined Therapy Withmetformin and Diabeton MB

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy